Ricardo R Fonseca

Summary

Country: Portugal

Publications

  1. doi request reprint Lymphangioma of the pancreas: a multimodal approach to pre-operative diagnosis
    R Fonseca
    Department of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
    Cytopathology 24:172-6. 2013
  2. ncbi request reprint Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer
    Ricardo R Fonseca
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil EPE, Lisboa, Portugal
    Am J Surg Pathol 30:1292-8. 2006
  3. doi request reprint HER2/neu detection by immunohistochemistry: optimization of in-house protocols
    Hugo M Lourenço
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil, Lisboa, Portugal
    Appl Immunohistochem Mol Morphol 17:151-7. 2009

Collaborators

Detail Information

Publications3

  1. doi request reprint Lymphangioma of the pancreas: a multimodal approach to pre-operative diagnosis
    R Fonseca
    Department of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
    Cytopathology 24:172-6. 2013
    ..Lymphangioma of the pancreas is an extremely rare benign tumour of lymphatic origin, with only four cases diagnosed by EUS-FNA reported to date...
  2. ncbi request reprint Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer
    Ricardo R Fonseca
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil EPE, Lisboa, Portugal
    Am J Surg Pathol 30:1292-8. 2006
    ..Therefore, despite their low incidence in MBC, expression abnormalities of ERBB2 behave, together with the pathologic stage of the tumor, as predictors of overall survival, akin to what has been reported for its female counterpart...
  3. doi request reprint HER2/neu detection by immunohistochemistry: optimization of in-house protocols
    Hugo M Lourenço
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil, Lisboa, Portugal
    Appl Immunohistochem Mol Morphol 17:151-7. 2009
    ..This in-house protocol for HER2 expression evaluation can be an efficient, specific, and accurate alternative to the FDA-approved kit in a more cost effective manner...